Cargando…

Development and Validation of an IoT Neurostimulator for the Treatment of Neurogenic Bladder

Neurogenic bladder is a dysfunction in the lower urinary tract due to damage to the nervous system. One of the treatments that has shown important results is transcutaneous neuromodulation. The neuromodulation equipment available on the market does not allow remote activation or offer many resources...

Descripción completa

Detalles Bibliográficos
Autores principales: Leal, Luana Cecilia Farache Lemos, Borges, Luiz Henrique Bertucci, De Paula, Maria Eduarda Franklin da Costa, Lisboa, Lilian Lira, Dantas, André Felipe Oliveira de Azevedo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674258/
https://www.ncbi.nlm.nih.gov/pubmed/38005670
http://dx.doi.org/10.3390/s23229284
_version_ 1785149688942428160
author Leal, Luana Cecilia Farache Lemos
Borges, Luiz Henrique Bertucci
De Paula, Maria Eduarda Franklin da Costa
Lisboa, Lilian Lira
Dantas, André Felipe Oliveira de Azevedo
author_facet Leal, Luana Cecilia Farache Lemos
Borges, Luiz Henrique Bertucci
De Paula, Maria Eduarda Franklin da Costa
Lisboa, Lilian Lira
Dantas, André Felipe Oliveira de Azevedo
author_sort Leal, Luana Cecilia Farache Lemos
collection PubMed
description Neurogenic bladder is a dysfunction in the lower urinary tract due to damage to the nervous system. One of the treatments that has shown important results is transcutaneous neuromodulation. The neuromodulation equipment available on the market does not allow remote activation or offer many resources for adjusting the parameters of the generated stimulus, as most devices operate with pre-established parameters in closed packages. For this reason, customizing therapy for each individual can be difficult. Therefore, the objective was to develop and validate a neuromodulation device capable of being remotely programmed and properly monitored. Materials and methods for validating devices were used according to the Brazilian Regulatory Standard (NBR), which deals with general requirements for the basic safety and essential performance of electromedical devices. After verifying the reliability of the device, which was capable of generating a biphasic and symmetrical wave, measured by an oscilloscope, considered safe by the technical requirements, it was tested in a real application. Users reported feeling a comfortable stimulus, similar to other previously used devices, and considered the device easy to use. In this way, it was possible to demonstrate the reliability and validity of the developed device.
format Online
Article
Text
id pubmed-10674258
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106742582023-11-20 Development and Validation of an IoT Neurostimulator for the Treatment of Neurogenic Bladder Leal, Luana Cecilia Farache Lemos Borges, Luiz Henrique Bertucci De Paula, Maria Eduarda Franklin da Costa Lisboa, Lilian Lira Dantas, André Felipe Oliveira de Azevedo Sensors (Basel) Article Neurogenic bladder is a dysfunction in the lower urinary tract due to damage to the nervous system. One of the treatments that has shown important results is transcutaneous neuromodulation. The neuromodulation equipment available on the market does not allow remote activation or offer many resources for adjusting the parameters of the generated stimulus, as most devices operate with pre-established parameters in closed packages. For this reason, customizing therapy for each individual can be difficult. Therefore, the objective was to develop and validate a neuromodulation device capable of being remotely programmed and properly monitored. Materials and methods for validating devices were used according to the Brazilian Regulatory Standard (NBR), which deals with general requirements for the basic safety and essential performance of electromedical devices. After verifying the reliability of the device, which was capable of generating a biphasic and symmetrical wave, measured by an oscilloscope, considered safe by the technical requirements, it was tested in a real application. Users reported feeling a comfortable stimulus, similar to other previously used devices, and considered the device easy to use. In this way, it was possible to demonstrate the reliability and validity of the developed device. MDPI 2023-11-20 /pmc/articles/PMC10674258/ /pubmed/38005670 http://dx.doi.org/10.3390/s23229284 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Leal, Luana Cecilia Farache Lemos
Borges, Luiz Henrique Bertucci
De Paula, Maria Eduarda Franklin da Costa
Lisboa, Lilian Lira
Dantas, André Felipe Oliveira de Azevedo
Development and Validation of an IoT Neurostimulator for the Treatment of Neurogenic Bladder
title Development and Validation of an IoT Neurostimulator for the Treatment of Neurogenic Bladder
title_full Development and Validation of an IoT Neurostimulator for the Treatment of Neurogenic Bladder
title_fullStr Development and Validation of an IoT Neurostimulator for the Treatment of Neurogenic Bladder
title_full_unstemmed Development and Validation of an IoT Neurostimulator for the Treatment of Neurogenic Bladder
title_short Development and Validation of an IoT Neurostimulator for the Treatment of Neurogenic Bladder
title_sort development and validation of an iot neurostimulator for the treatment of neurogenic bladder
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674258/
https://www.ncbi.nlm.nih.gov/pubmed/38005670
http://dx.doi.org/10.3390/s23229284
work_keys_str_mv AT lealluanaceciliafarachelemos developmentandvalidationofaniotneurostimulatorforthetreatmentofneurogenicbladder
AT borgesluizhenriquebertucci developmentandvalidationofaniotneurostimulatorforthetreatmentofneurogenicbladder
AT depaulamariaeduardafranklindacosta developmentandvalidationofaniotneurostimulatorforthetreatmentofneurogenicbladder
AT lisboalilianlira developmentandvalidationofaniotneurostimulatorforthetreatmentofneurogenicbladder
AT dantasandrefelipeoliveiradeazevedo developmentandvalidationofaniotneurostimulatorforthetreatmentofneurogenicbladder